Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
Study of SDX in Patients With Idiopathic Hypersomnia (IH)NCT05668754Zevra TherapeuticsPhase 2Completed2024-02-28Actual
Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisNCT05671835Tvardi Therapeutics, IncorporatedPhase 2Completed2025-08-14Actual
AMX0035 in Adult Patients With Wolfram SyndromeNCT05676034AMLXPhase 2Active not recruiting2024-07-23Actual
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaNCT05678673ExelixisPhase 3Active not recruiting2026-12-15Estimated
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic MigraineNCT05679908Tonix Pharmaceuticals, Inc.Phase 2Completed2023-10-08Actual
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)NCT05681351IONSPhase 3Active not recruiting2027-03Estimated
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044ANVSPhase 2, Phase 3Completed2024-02-13Actual
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)NCT05686408Tonix Pharmaceuticals, Inc.Phase 2Completed2023-09-29Actual
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142RGNXPhase 2, Phase 3Active not recruiting2026-09Estimated
A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisNCT05695950LKFTPhase 2Completed2025-10-13Actual
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT05696626LeonaBioPhase 3Recruiting2027-04Estimated
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyNCT05696717Theravance BiopharmaPhase 3Active not recruiting2026-01Estimated
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseaseNCT05709444PTNPhase 2Completed2024-04-26Actual
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940COMPASS PathwaysPhase 3Active not recruiting2025-11-13Actual
Phase 2b Study of ALTO-100 in MDDNCT05712187Alto NeurosciencePhase 2Completed2024-09-05Actual
A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsNCT05712356LSTAPhase 2Completed2026-04-05Actual
Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)NCT05712694Polaris GroupPhase 3Terminated2026-05-25Actual
Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell TherapyNCT05714345Allogene TherapeuticsPhase 2Terminated2024-02-20Actual
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)NCT05716100XENEPhase 3Recruiting2028-01Estimated
A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)NCT05717920ALDXPhase 2Completed2023-11-21Actual
An Open-label Study of XEN1101 in EpilepsyNCT05718817XENEPhase 3Enrolling by invitation2033-04Estimated
Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose ExcursionsNCT05721729VOGXPhase 2Completed2024-05-01Actual
A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated PatientsNCT05725018ABEOPhase 3Active not recruiting2025-09-30Estimated
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.NCT05727904IOVAPhase 3Recruiting2028-03-01Estimated
Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)NCT05731544BMEAPhase 1, Phase 2Completed2024-11-18Actual
A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive DisorderNCT05733546COMPASS PathwaysPhase 2Active not recruiting2025-09Estimated
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCNCT05733598Replimune, Inc.Phase 2Recruiting2027-12-01Estimated
RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRCNCT05733611Replimune, Inc.Phase 2Terminated2025-08-18Actual
To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MNCT05733780Bioxytran Inc.Phase 2Unknown2023-12Estimated
Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque PsoriasisNCT05739435ALMSPhase 2Active not recruiting2027-12-01Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.